We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current PPHOF market cap is 146.79M. The company's latest EPS is CHF -0.3160 and P/E is -7.91.
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Total Revenue | 6.99M | 10k | 14.28M | 0 | 0 |
| Operating Income | -46.66M | -64.92M | -42.39M | -4.25M | -18.67M |
| Net Income | -50.92M | -64.67M | -44.95M | -11.86M | -18.55M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Total Assets | 144.09M | 92.77M | 46.77M | 49.9M | 29.95M |
| Total Liabilities | 23.44M | 37.66M | 33.28M | 19.67M | 10.55M |
| Total Equity | 120.66M | 55.11M | 13.49M | 30.22M | 19.4M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Operating | -43.99M | -56.01M | -42.36M | -1.13M | -11.96M |
| Investing | 2.04M | 1.38M | -48k | 3.43M | -17k |
| Financing | 151.15M | -1.48M | 1.09M | 11.83M | -1.33M |
| Market Cap | 146.79M |
| Price to Earnings Ratio | -7.91 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 81.43 |
| Price to Book Ratio | 7.57 |
| Dividend Yield | - |
| Shares Outstanding | 58.71M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (0%) |
| Company Name | Spexis AG (CE) |
| Address |
hegenheimermattweg 125 allschwil 4123 |
| Website | https://www.polyphor.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
